Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Keane

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Synapse (New York, N.Y.)|April 1, 1995
Effects of the sigma receptor ligand SR 31742A on neurotensin biosynthesis in rat basal gangliaC Labie, P Saubusse, P E Keane, et al.
Epilepsia|January 1, 1984
Valproate: recent findings and perspectivesM Morre, P E Keane, J C Vernières, et al.
Progress in Neurobiology|January 1, 1982
Mechanism of anticonvulsant action of valproateA Chapman, P E Keane, B S Meldrum, et al.
Brain Research|December 2, 1985
Growth hormone-releasing factor modifies dopaminergic but not serotonergic activity in the arcuate nucleus of hypothalamus in the rat, as recorded in vivo by differential pulse voltammetryF Crespi, J Paret, P E Keane, et al.
Fundamental & Clinical Pharmacology|January 1, 1993
Neuropsychopharmacological profile in rodents of SR 57746A, a new, potent 5-HT1A receptor agonistJ Simiand, P E Keane, M C Barnouin, et al.
The Journal of Pharmacy and Pharmacology|May 26, 1998
The non-peptide neuroprotective agents SR 57746A interacts with neurotrophin 3 to induce differentiation in the PC12 cell-lineJ Fournier, G Boutot, P E Keane, et al.
British Journal of Pharmacology|June 16, 1999
Effect of the neuroprotective compound SR57746A on nerve growth factor synthesis in cultured astrocytes from neonatal rat cortexC Labie, C Lafon, C Marmouget, et al.
British Journal of Pharmacology|August 5, 1998
The effect of the nonpeptide neurotrophic compound SR 57746A on the progression of the disease state of the pmn mouseF Duong, J Fournier, P E Keane, et al.
European Journal of Pharmacology|August 25, 1992
Antidepressant profile in rodents of SR 58611A, a new selective agonist for atypical beta-adrenoceptorsJ Simiand, P E Keane, J Guitard, et al.
European Journal of Pharmacology|June 14, 2000
Characterisation of the effects of SR146131, a novel non-peptide CCK(1) receptor agonist, on IMR-32 human neuroblastoma cellsP Schaeffer, A L Nestor, V Prabonnaud, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Synapse (New York, N.Y.)|April 1, 1995
Effects of the sigma receptor ligand SR 31742A on neurotensin biosynthesis in rat basal gangliaC Labie, P Saubusse, P E Keane, et al.
Epilepsia|January 1, 1984
Valproate: recent findings and perspectivesM Morre, P E Keane, J C Vernières, et al.
Progress in Neurobiology|January 1, 1982
Mechanism of anticonvulsant action of valproateA Chapman, P E Keane, B S Meldrum, et al.
Brain Research|December 2, 1985
Growth hormone-releasing factor modifies dopaminergic but not serotonergic activity in the arcuate nucleus of hypothalamus in the rat, as recorded in vivo by differential pulse voltammetryF Crespi, J Paret, P E Keane, et al.
Fundamental & Clinical Pharmacology|January 1, 1993
Neuropsychopharmacological profile in rodents of SR 57746A, a new, potent 5-HT1A receptor agonistJ Simiand, P E Keane, M C Barnouin, et al.
The Journal of Pharmacy and Pharmacology|May 26, 1998
The non-peptide neuroprotective agents SR 57746A interacts with neurotrophin 3 to induce differentiation in the PC12 cell-lineJ Fournier, G Boutot, P E Keane, et al.
British Journal of Pharmacology|June 16, 1999
Effect of the neuroprotective compound SR57746A on nerve growth factor synthesis in cultured astrocytes from neonatal rat cortexC Labie, C Lafon, C Marmouget, et al.
British Journal of Pharmacology|August 5, 1998
The effect of the nonpeptide neurotrophic compound SR 57746A on the progression of the disease state of the pmn mouseF Duong, J Fournier, P E Keane, et al.
European Journal of Pharmacology|August 25, 1992
Antidepressant profile in rodents of SR 58611A, a new selective agonist for atypical beta-adrenoceptorsJ Simiand, P E Keane, J Guitard, et al.
European Journal of Pharmacology|June 14, 2000
Characterisation of the effects of SR146131, a novel non-peptide CCK(1) receptor agonist, on IMR-32 human neuroblastoma cellsP Schaeffer, A L Nestor, V Prabonnaud, et al.
Pageof 5